Navigation Links
Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Date:9/4/2007

nse drug ISIS 325568 for type 2 diabetes. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward- looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2006, and its quarterly report on Form 10-Q for the quarter ended June 30, 2007, which are on file with the SEC. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Malvern initiates European user group meetings for chemical imaging
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
(Date:8/27/2014)... -- Kewaunee Scientific Corporation (Nasdaq: KEQU ) ... cash dividend by 9% to twelve cents per outstanding ... the dividend payable on September 22, 2014 to stockholders ... 8, 2014. About Kewaunee Scientific ... is a recognized global leader in the design, manufacture, ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 /PRNewswire/ ... Co., Ltd, ("Menovo") today announced they had entered into ... primarily targeting the United States ... Menovo will jointly develop products for Amerigen to commercialize ... will be responsible for manufacturing API and finished product ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... The Halifax Health - Betty Jane France Center ... of a new decade of caring by unveiling a ... held this afternoon in Daytona Beach, Fla. ... will celebrate the 10th anniversary of Speediatrics. In recognition ...
... flu hospitalization rates for African-Americans, Hispanics, and American Indian/Alaska ... for Whites during the 2009-2010 flu season, according to ... the Trust for America,s Health (TFAH). At the same ... lower for African Americans and Hispanics than for Whites. ...
Cached Medicine Technology:Speediatrics Unit Celebrates 10th Anniversary 2Speediatrics Unit Celebrates 10th Anniversary 3New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 2New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 3New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 4
(Date:8/28/2014)... August 28, 2014 Dr. Bryan McIntosh ... downloadable ebook guide to the tummy tuck cosmetic ... surgery, the procedure itself, and how to recover well ... candid explanations. Dr. McIntosh also discusses how to have ... ensure that the procedure is as successful as possible. ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Dr. ... many young patients throughout the summer that recently headed ... for Education Statistics, over 22 million students will ... Students may spend their time attending classes, studying for ... increase their risk of eye problems. , Dr. ...
(Date:8/28/2014)... Mexico (PRWEB) August 28, 2014 Postcard-worthy ... Cortez and exclusive glamping by the beach in your ... at Villa del Palmar at the Islands of Loreto. ... offering newlyweds an unforgettable experience in paradise with its ... through October 8, 2014. , “Villa del Palmar at ...
(Date:8/28/2014)... August 28, 2014 A leading Florida ... of suicide contagion as a result of media coverage surrounding ... an increased risk of ‘copycat suicides’ among the general public. ... should not be on what happened—the suicide itself—but on what ... suicide. , “Suicide is a tragedy on so many ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 Bleeding gums ... rough brushing or flossing, according to the prosthodontists at the ... cause by some serious medical conditions, Dr. Saj Jivraj and ... , “If you are not properly cleaning your teeth all ... become inflamed and bleed easily,” Dr. Jivraj said. , Despite ...
Breaking Medicine News(10 mins):Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 4Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 2Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 3Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 4Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 5
... but good habits can help you cope, experts say , ... the mental decline associated with old age, engage in intellectually ... social life. , Those are the findings of what ... and the brain. , The review, which spanned three decades ...
... June 24 How happy are you? Would you like to be,happier? ... What is it? , TopTips.com,s ... time, not for a long time by bringing you Top Tips for,Happiness. ... Happiness for the nation to,commit and asking you to send in your ...
... June 24 Novasys Medical, Inc., a developer of ... of July 1, 2009, First Coast Service Options, Inc. ... 3 million beneficiaries in Florida, Puerto Rico and the ... for women with stress urinary incontinence (SUI) from its ...
... LOUIS, June 24 Mercy Health Plans (MHP) is ... solution through MHP,s website at www.mercyhealthplans.com ... designed to connect individual insurance shoppers and brokers with ... , , Mercy One Connect(TM) utilizes ...
... Purchase Agreement will expedite the purchasing process for groups ... IRVINE, Calif., June 24 ChromaDex Corp., (OTC Bulletin ... contract research, announced today that the National Institutes of ... Company. The Agreement covers all products and services ...
... , , , Chocolate and Candy Remain ... 24 Experimenting with flavors, flexibility and variety, confectionery makers ... and candy innovation that will drive consumer purchasing over the ... Confectionery Industry Trend Report 2009. Even in economic uncertainty, the ...
Cached Medicine News:Health News:Stay Upbeat, Active to Keep the Mind Young 2Health News:Stay Upbeat, Active to Keep the Mind Young 3Health News:The Secret of Happiness 2Health News:The Secret of Happiness 3Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 2Health News:First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women 3Health News:Mercy Health Plans Launches MercyOne Connect(TM) 2Health News:ChromaDex Establishes a Blanket Purchase Agreement With the National Institutes of Health 2Health News:Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations 2Health News:Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations 3Health News:Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations 4Health News:Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations 5Health News:Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations 6
... The SourceLink™ Delivery System offers a ... It addresses the challenges associated with ... provides the flexibility of seed and ... packaged per customers desired quantity and ...
... The Bard EXPRESS Seeding Cartridge System is ... delivering radioactive seeds and spacers into a ... Each cartridge has a(n): outer radiation safety ... synthetic absorbable spacers, integrally molded fitting that ...
... The Sysmex UF-100 is designed to ... microscopic analysis. It combines the superior ... automated urine sample analysis. Continuous sampling ... the rack-based autosamplers, streamlining sample processing in ...
... Q-Track II Holter Monitoring System uses technology ... the worlds first true 12-lead digital Holter ... of any beat contained in the 24-hour ... ,The preprocessing work done by the Q-12 ...
Medicine Products: